| Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κB signaling pathway PC Lucas, M Yonezumi, N Inohara, LM McAllister-Lucas, ME Abazeed, ... Journal of Biological Chemistry 276 (22), 19012-19019, 2001 | 541 | 2001 |
| Therapy-induced senescence: opportunities to improve anticancer therapy PG Prasanna, DE Citrin, J Hildesheim, MM Ahmed, S Venkatachalam, ... JNCI: Journal of the National Cancer Institute 113 (10), 1285-1298, 2021 | 183 | 2021 |
| An image-based deep learning framework for individualising radiotherapy dose: a retrospective analysis of outcome prediction B Lou, S Doken, T Zhuang, D Wingerter, M Gidwani, N Mistry, L Ladic, ... The Lancet Digital Health 1 (3), e136-e147, 2019 | 180 | 2019 |
| Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy Z Li, M Alyamani, J Li, K Rogacki, M Abazeed, SK Upadhyay, SP Balk, ... Nature 533 (7604), 547-551, 2016 | 167 | 2016 |
| A genetic basis for the variation in the vulnerability of cancer to DNA damage BD Yard, DJ Adams, EK Chie, P Tamayo, JS Battaglia, P Gopal, ... Nature communications 7 (1), 11428, 2016 | 164 | 2016 |
| Integrative radiogenomic profiling of squamous cell lung cancer ME Abazeed, DJ Adams, KE Hurov, P Tamayo, CJ Creighton, D Sonkin, ... Cancer research 73 (20), 6289-6298, 2013 | 133 | 2013 |
| Characterizing genomic alterations in cancer by complementary functional associations JW Kim, OB Botvinnik, O Abudayyeh, C Birger, J Rosenbluh, Y Shrestha, ... Nature biotechnology 34 (5), 539-546, 2016 | 101 | 2016 |
| A histologic basis for the efficacy of SBRT to the lung NM Woody, KL Stephans, M Andrews, T Zhuang, P Gopal, P Xia, ... Journal of Thoracic Oncology 12 (3), 510-519, 2017 | 97 | 2017 |
| Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer A Dhawan, D Nichol, F Kinose, ME Abazeed, A Marusyk, EB Haura, ... Scientific reports 7 (1), 1232, 2017 | 92 | 2017 |
| The Vps13p–Cdc31p complex is directly required for TGN late endosome transport and TGN homotypic fusion M De, AN Oleskie, M Ayyash, S Dutta, L Mancour, ME Abazeed, EJ Brace, ... Journal of Cell Biology 216 (2), 425-439, 2017 | 91 | 2017 |
| The implications of genetic testing on radiation therapy decisions: a guide for radiation oncologists C Bergom, CM West, DS Higginson, ME Abazeed, B Arun, SM Bentzen, ... International Journal of Radiation Oncology* Biology* Physics 105 (4), 698-712, 2019 | 86 | 2019 |
| Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures R Vander Velde, N Yoon, V Marusyk, A Durmaz, A Dhawan, ... Nature communications 11 (1), 2393, 2020 | 82 | 2020 |
| Consequences of mutant TET2 on clonality and subclonal hierarchy CM Hirsch, A Nazha, K Kneen, ME Abazeed, M Meggendorfer, ... Leukemia 32 (8), 1751-1761, 2018 | 63 | 2018 |
| Transcriptomic and protein analysis of small-cell bladder cancer (SCBC) identifies prognostic biomarkers and DLL3 as a relevant therapeutic target VS Koshkin, JA Garcia, J Reynolds, P Elson, C Magi-Galluzzi, ... Clinical Cancer Research 25 (1), 210-221, 2019 | 54 | 2019 |
| Molecular characteristics of biliary tract cancer DPS Sohal, S Shrotriya, M Abazeed, M Cruise, A Khorana Critical Reviews in Oncology/Hematology 107, 111-118, 2016 | 53 | 2016 |
| A Therapeutic Strategy for Preferential Targeting of TET2-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms Y Guan, AD Tiwari, JG Phillips, M Hasipek, DR Grabowski, S Pagliuca, ... Blood cancer discovery 2 (2), 146-161, 2021 | 45 | 2021 |
| Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia H Awada, Y Nagata, A Goyal, MF Asad, B Patel, CM Hirsch, ... Blood advances 3 (3), 339-349, 2019 | 39 | 2019 |
| Cell-free transport from the trans-golgi network to late endosome requires factors involved in formation and consumption of clathrin-coated vesicles ME Abazeed, JM Blanchette, RS Fuller Journal of Biological Chemistry 280 (6), 4442-4450, 2005 | 38 | 2005 |
| Radiotherapy in the era of precision medicine B Yard, EK Chie, DJ Adams, C Peacock, ME Abazeed Seminars in radiation oncology 25 (4), 227-236, 2015 | 37 | 2015 |
| Inhibition of protein synthesis by didemnins: Cell potency and SAR D Ahuja, A Geiger, JM Ramanjulu, MD Vera, B SirDeshpande, ... Journal of medicinal chemistry 43 (22), 4212-4218, 2000 | 37 | 2000 |
Omar Y. Mian, M.D., Ph.D.Translational Hematology and Oncology Research, Cleveland ClinicVerified email at ccf.org
